Revlimid 25 — Lenalidomide 25 mg, 100 pcs, Bristol-Myers Squibb
100% original product

Revlimid 25 — Lenalidomide 25 mg (100 Capsules)

163335₴ 169956₴ -4%

Revlimid (Lenalidomide) is a potent antineoplastic immunomodulator, a member of the IMiDs group. The drug possesses a unique triple mechanism of action: it directly inhibits the growth of malignant cells, blocks the development of blood vessels within the tumor (anti-angiogenic effect), and activates the body's own immune cells (T-cells and NK-cells) to fight cancer. Lenalidomide is a derivative of thalidomide but features significantly higher therapeutic activity and an improved safety profile.

Revlimid has revolutionized the treatment of multiple myeloma, transforming it from an acute disease into a manageable chronic condition. The drug works effectively both as part of combination therapy and as maintenance treatment after stem cell transplantation.

Key Features:

  • Multimodal Action: Combines a direct attack on the tumor with potent stimulation of anti-tumor immunity.
  • High Efficacy in MDS: The drug of choice for patients with myelodysplastic syndrome associated with the 5q deletion.
  • Convenience: Oral form (capsules) allows for outpatient treatment.

Revlimid (Lenalidomide) is used for the treatment of adult patients with the following diseases:

  • 🔹 Multiple Myeloma: In combination with dexamethasone or as maintenance therapy after bone marrow transplantation.
  • 🔹 Myelodysplastic Syndromes (MDS): Treatment of patients with anemia caused by low or intermediate-1 risk MDS with a cytogenetic abnormality (5q deletion).
  • 🔹 Mantle Cell Lymphoma (MCL): Treatment of patients with relapsed or refractory disease.
  • 🔹 Follicular Lymphoma: In combination with rituximab for the treatment of previously treated patients.

Sales Form: 1 pack contains 100 capsules of 25 mg (as per image).

⚠️ INSTRUCTIONS FOR USE:

  • Dosage Regimen: Dosage and schedule (e.g., 21 days of treatment followed by 7 days off) are determined by a hematologist based on diagnosis and blood counts.
  • Method: Capsules should be taken at approximately the same time, swallowed whole. Capsules must not be opened, broken, or chewed.
  • Monitoring: Strict monitoring of complete blood count is required throughout treatment (weekly during the first months of therapy).
  • Thrombosis Prevention: Often prescribed alongside aspirin or anticoagulants to reduce the risk of blood clots.
  • Storage: At a temperature not exceeding 25°C in a dry place.
  • Pregnancy (CRITICALLY IMPORTANT): Lenalidomide is structurally related to thalidomide and possesses severe teratogenic effects. It is strictly contraindicated in pregnant women.
  • Family Planning: Both women and men must use strict methods of contraception. Women must not become pregnant, and men must not father a child during treatment and for 4 weeks after completion.
  • Lactation: Breastfeeding is prohibited.
  • Hypersensitivity: Allergic reactions to lenalidomide or thalidomide.
  • Age: Safety for children under 18 years of age has not been established.

Taking Revlimid requires close medical supervision due to potential serious side effects:

  • 🩸 Hematology: Neutropenia (low white blood cell count) and thrombocytopenia (risk of bleeding). These are the most common side effects.
  • 🦵 Thromboembolism: Increased risk of deep vein thrombosis and pulmonary embolism.
  • 🧪 Digestion: Diarrhea, constipation, nausea, abdominal pain.
  • 🩹 Skin Reactions: Muscle cramps, itching, rash.
  • 🤒 Infections: Increased susceptibility to viral and bacterial diseases.
  • ⚠️ Important: If shortness of breath, chest pain, leg swelling, or signs of infection (fever) occur, seek medical attention immediately.
Active ingredient
Manufacturer
Bristol-Myers Squibb
Dosage 25 mg
Dosage form Capsules
Capsules per pack 100
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00